Astec Lifescienc (ASTEC)
TurnaroundFairStock Score: 6/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹593.95 |
| Market Cap | ₹1,323.45 Cr |
| P/E Ratio | 0 |
| ROCE | -12.86% |
| ROE | -30.71% |
| Dividend Yield | 0% |
| Profit Growth | 43.31% |
| Debt/Equity | 1.15 |
| Sales Growth | -7.97% |
| Promoter Holding | 71.97% |
| 52-Week Range | ₹513.4 — ₹941.75 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹175.3 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me start with what I understand: Astec Lifescienc sells pesticides and agrochemicals. In farming-linked businesses, a cheap product with reliable distribution can be valuable, but the numbers here do not yet support that. The company is losing money—latest quarter sales of ₹125 Cr produced a net loss of ₹16 Cr. Annual returns are deeply negative: ROE is -30.71% and ROCE is -12.86%. A business that earns no returns on equity or capital, while carrying Debt/Equity of 0.89, is not a compounding machine; it is a consumption machine. The P/E being 0.00 is not a bargain signal—it is an earnings absence signal. Paying ₹733.85 per share, or 5.58 times book value of ₹131.57, for such negative profitability is the opposite of margin of safety.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer